3,4-Methylenedioxymephenidine
| UWA-001 | |
|---|---|
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 255.31 g/mol [1] |
| Predicted LogP | 3.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H17NO2 [1] |
| IUPAC name | 2-(1,3-benzodioxol-5-yl)-N-methyl-1-phenylethanamine [1] |
| SMILES | CNC(CC1=CC2=C(C=C1)OCO2)C3=CC=CC=C3 [1] |
| InChI | InChI=1S/C16H17NO2/c1-17-14(13-5-3-2-4-6-13)9-12-7-8-15-16(10-12)19-11-18-15/h2-8,10,14,17H,9,11H2,1H3 [1] |
| InChIKey | DNOTUUOUOFJQJC-UHFFFAOYSA-N [1] |
3,4-Methylenedioxymephenidine (also known as α-Phenyl-mdma, UWA-001, Unii-zq2r4kpz2w, N-Methyl-α-phenyl-1,3-benzodioxole-5-ethanamine, 1,3-Benzodioxole-5-ethanamine, N-methyl-α-phenyl-, Chembl3303514, Schembl25224327, Dtxsid301045824, N-methyl-α-phenyl-1,3-benzodioxole-5-ethanamine or 1,3-Benzodioxole-5-ethanamine, n-methyl-α-phenyl-) is a entactogen and cytotoxin substance of the 3,4-methylenedioxyphenethylamine and 1,2-diarylethylamine class.
Chemistry
Stereochemistry []
3,4-Methylenedioxymephenidine is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 17757315, Methylenedioxymephenidine. Accessed May 6, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/17757315
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 3,4-Methylenedioxymephenidine. UNII: ZQ2R4KPZ2W. Global Substance Registration System. Accessed May 6, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/ZQ2R4KPZ2W